Mucosal administration of anti-bacterial antibody (Ab) provides long-term cross-protection against Pseudomonas aeruginosa respiratory infection
Autor: | A Pitiot, M Ferreira, C Parent, C Boisseau, M Cortes, L Bouvart, N Aubrey, C Paget, N Heuzé-Vourc'H, T Secher |
---|---|
Rok vydání: | 2022 |
Zdroj: | 10.01 - Respiratory infections and bronchiectasis. |
DOI: | 10.1183/13993003.congress-2022.1818 |
Databáze: | OpenAIRE |
Externí odkaz: |